Genome‐wide association studies identify novel loci in rapidly progressive Alzheimer's disease

Ping Wang,Audrey Lynn,Kristy Miskimen,Yeunjoo E. Song,Thomas Wisniewski,Mark Cohen,Brian S. Appleby,Jiri G. Safar,Jonathan L. Haines
DOI: https://doi.org/10.1002/alz.13655
2024-01-09
Alzheimer s & Dementia
Abstract:INTRODUCTION Recent data suggest that distinct prion‐like amyloid beta and tau strains are associated with rapidly progressive Alzheimer's disease (rpAD). The role of genetic factors in rpAD is largely unknown. METHODS Previously known AD risk loci were examined in rpAD cases. Genome‐wide association studies (GWAS) were performed to identify variants that influence rpAD. RESULTS We identified 115 pathology‐confirmed rpAD cases and 193 clinical rpAD cases, 80% and 69% were of non‐Hispanic European ancestry. Compared to the clinical cohort, pathology‐confirmed rpAD had higher frequencies of apolipoprotein E (APOE) ε4 and rare missense variants in AD risk genes. A novel genome‐wide significant locus (P
clinical neurology
What problem does this paper attempt to address?